Banner displaying the Vital Tones logo and company name.

RESEARCH

Unveiling Breakthroughs
in Neuroscience

At Vital Tones, we are dedicated to advancing neuroscience through non-invasive, precision-driven technologies. Our proprietary Deep Brain Sound Stimulation (DBSS) technology uses targeted auditory stimulation to treat a range of neurological, psychological, and physical disorders. By activating specific brain regions with sound, DBSS offers a unique, low-risk alternative to traditional therapies, with promising results across various conditions.

 

Below, you’ll find an overview of our published and ongoing research, highlighting DBSS’s potential to transform mental health, cognitive function, and physical health.

 

New Book Release

To further share the principles and applications of our work, we’ve published a new book:

​

​The Maker’s CodexAvailable on:Apple BooksGoogle Play BooksGoogle Play AudiobookAmazon — KindleAmazon — PaperbackAmazon — Hardcover

Published and Preprint Research

Our research portfolio includes both peer-reviewed publications and preprints available for public access. One study has been fully peer-reviewed and published, while others are currently available as preprints and are in the process of peer review in various journals, with expected publication in 2025. Each report showcases the versatility and effectiveness of DBSS across different therapeutic applications. Click on any study title to access the full report.

 

Peer-Reviewed Publication:

 

 

Preprints (Under Review for Publication):

 

Joint and Ligament Regeneration Using DBSS

 

  • Audio Brainwave Treatment Restores Chronic ACL–PCL Ruptures: MRI-Verified Case Report
    This new preprint highlights a powerful direction for DBSS: helping the body regenerate from chronic physical damage. In this case, a patient with long-standing ACL–PCL knee injuries showed visible improvement after using a Vital Tones sound-based stimulation protocol—confirmed by MRI scans before and after treatment.

    The results open the door to non-invasive recovery for ligaments, joints, and other physical injuries—without surgery or medication.
    • Evidence: Pre- and post-MRI scans showing improvement
    • Safety: No side effects reported

We are now collecting more MRI cases to prepare a larger, multi-patient clinical report.

If you're interested in contributing to this study, please refer to the full report for participation information.

 

Core DBSS Technology and Overview

 

    • Study Scope: Over 6,400 users across 50 therapy applications
    • User Satisfaction: 98.5%
    • Safety: Minimal adverse effects
    • Reported Benefits: Cognitive, emotional, and motor improvements across conditions such as anxiety, depression, ADHD, Parkinson’s disease, and PTSD

 

Neurological and Psychological Disorders

 

    • Effectiveness: 50% improvement in mood regulation
    • User Satisfaction: 99.59%

 

    • Effectiveness: 65% improvement in mood stability
    • User Satisfaction: 97.78%

 

    • Effectiveness: 65% reduction in anxiety symptoms
    • User Satisfaction: 99.03%

 

    • Effectiveness: 50% improvement reported for DTD, and 80% for PTSD in symptom reduction
    • User Satisfaction: 97.50% for DTD, 99.47% for PTSD

 

    • Effectiveness: 57% improvement in ADHD symptoms, including attention and hyperactivity
    • User Satisfaction: 99.77%

 

    • Effectiveness: 65% improvement in phonological awareness and reading fluency
    • User Satisfaction: 100%

 

    • Effectiveness: 80% for Insomnia, 65% for Deep Sleep
    • User Satisfaction: 99.30% (Insomnia), 99.53% (Deep Sleep)

 

    • Effectiveness:50% reduction in OCD symptoms
    • User Satisfaction: 99.12%

 

    • Effectiveness: 50% improvement in emotional regulation and impulsivity
    • User Satisfaction: 99.26%

 

 

Menstrual Pain Relief Using DBSS (Public Study in Progress):

A publicly available 14-minute sound-based session is currently being evaluated for menstrual pain relief. The protocol is designed to reduce lower-abdominal tension, relax the nervous system, and ease discomfort associated with menstruation. Participants are invited to submit feedback approximately 24 hours after use. As appreciation, participants receive free access to Alignment 108 Pro.

 

YouTube Session

 

Feedback Form

 

 

Stuttering Fluency Improvement (Public Study in Progress)

A single 5-minute sound-based session is now being evaluated for speech fluency improvement in individuals who stutter. Early testers have reported noticeably smoother speech and higher confidence after listening once. We are inviting additional participants to help gather further data. The session is included within the form for direct listening and response.

 

Feedback Form

 

 

Severe Knee Degeneration (Ongoing Single-Case Observation):

This case involves advanced knee degeneration, including cartilage erosion, ligament weakening, bone deformity, and synovial fluid loss. Prior to treatment, the participant experienced severe chronic pain and was advised to undergo partial knee prosthesis surgery. Joint-fluid injections provided only temporary relief. During therapy, the participant has reported significant reductions in pain, improved mobility, and the ability to climb stairs without support. Sessions are ongoing to support further recovery.

 

Findings: Continued improvement in pain, mobility, and daily function

Safety: No adverse side effects reported

Limitations: Single-case observation; follow-up MRI pending

 

This exploratory case suggests potential non-invasive support for degenerative joint conditions where surgical intervention is commonly recommended.

 

 

Lumbar Disc Herniation (Ongoing Single-Case Observation):

This case involves lumbar disc herniation, a major contributor to chronic low back pain affecting up to 80% of people at some point in their lives. The participant previously relied on two strong pain-medications daily, providing only temporary relief. After three weeks of therapy, pain symptoms fully resolved. The participant completed 1.5 months of treatment and has now paused for three weeks to monitor for possible symptom recurrence before undergoing a post-treatment MRI evaluation.

 

Findings: Complete remission of pain after three weeks of therapy

Safety: No adverse side effects reported

Limitations: Single-case observation; post-treatment MRI pending

 

This exploratory case suggests potential non-invasive symptom relief for lumbar disc herniation, potentially reducing reliance on medication and invasive interventions.

 

 

Age-Related Macular Degeneration (Ongoing Single-Case Observation)

This case involves age-related macular degeneration (AMD) with progressive central vision loss. The 88-year-old participant presented with severely reduced visual acuity, historically limited to approximately 40–50% in the left eye and 5–10% in the right eye, with the right eye able to detect only light sources. Previous clinical management included anti-inflammatory and anti-VEGF injections, as well as intraocular lens optimization, each reaching usage limits without meaningful improvement. No conventional therapeutic options remained available.

 

During ongoing therapy, the participant has reported notable improvements in the functional vision of the right eye, including clearer perception of objects previously indistinguishable. Follow-up assessment using Optical Coherence Tomography (OCT) imaging is planned to evaluate retinal changes.

 

Findings: Subjective improvement in central visual perception, especially in the right eye

Safety: No adverse side effects reported

Limitations: Single-case observation; follow-up OCT pending

 

This exploratory case suggests potential non-invasive support for visual function in age-related macular degeneration, particularly in situations where pharmacologic and procedural options are exhausted.

 

 

Nocturnal Epilepsy (Ongoing Single-Case Observation)

This case involves nocturnal seizure activity occurring exclusively during sleep, historically averaging 20–40 episodes per night with no daytime events. During therapy, nightly seizure frequency has been reduced to a maximum of two. The current objective is to reach zero episodes while maintaining medication, followed by gradual medication tapering to assess long-term stability.

 

Findings: Significant reduction of nocturnal seizures from 20–40 to ≤2 per night

Safety: No adverse side effects reported

Limitations: Single-case observation; long-term medication withdrawal pending

 

This exploratory case suggests potential support for nocturnal seizure control in individuals who remain symptomatic despite conventional management.

 

 

Upcoming Reports

Our research is continuously expanding, with additional studies nearing completion. We anticipate that most of these reports will be available as preprints by the end of this year, allowing us to further demonstrate DBSS’s therapeutic versatility.

 

  • Advancing Brainwave Therapy for Schizophrenia
  • Advancing Brainwave Therapy for Restless Legs Syndrome (RLS)
  • Advancing Brainwave Therapy for Migraine
  • Advancing Brainwave Therapy for Fibromyalgia
  • Advancing Brainwave Therapy for Stress

 

 

Future Directions and Exploratory Research

Current initiatives include:

 

  • Stage 2 Studies for Resistant Hypertension: Early results indicate potential support for managing blood pressure in cases unresponsive to medication. Further validation is in progress.

 

  • Exploratory Research on Brain-Immune Interaction: Investigations are underway to assess how sound-based neuromodulation may influence immune regulation, with the goal of identifying new pathways for treating immune-related disorders.

 

Collaboration and Licensing Opportunities

Vital Tones is actively seeking partnerships to expand the research, validation, and clinical applications of DBSS. We invite inquiries from:

  • Research Labs: Collaborate with us to further study DBSS technology or conduct pilot programs. Labs can contribute to the growing body of evidence supporting DBSS and potentially explore new applications.
  • Clinical Partners: Clinics and healthcare providers interested in implementing DBSS for patient treatment are encouraged to reach out to explore collaborative possibilities.
  • Investors: We are seeking investment to scale DBSS technology and accelerate its adoption. Our extensive research and early positive feedback position DBSS as a transformative non-invasive technology in neuroscience and mental health.

 

For serious inquiries, we offer additional details on licensing terms and customizable collaboration options. Please contact us directly at [email protected] to learn more.

 

Join Our Mission

Vital Tones is seeking passionate individuals with expertise in neuroscience, clinical research, business development, and other related fields to join our groundbreaking work with DBSS technology. If you’re inspired by the potential of non-invasive brain stimulation and want to contribute to a pioneering endeavor in neuroscience, we encourage you to connect with us.

 

 

 

 

 

Vital Tones - Connect with Us
Connect with Vital Tones

Return to Main Page

VITAL TONES 2015